Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
28.87
-2.52 (-8.03%)
Apr 3, 2025, 4:00 PM EDT - Market closed

Crinetics Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020 2016 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Net Income
-298.41-214.53-163.92-107.64-73.81
Upgrade
Depreciation & Amortization
2.791.10.980.920.95
Upgrade
Loss (Gain) From Sale of Assets
0.050.01---
Upgrade
Loss (Gain) From Sale of Investments
-14.93-6.270.030.42-0.23
Upgrade
Loss (Gain) on Equity Investments
0.475.21.01--
Upgrade
Stock-Based Compensation
69.3940.9428.2717.3510.43
Upgrade
Other Operating Activities
3.04-0.79-0.19-0.740.26
Upgrade
Change in Accounts Payable
17.5414.6510.996.292.72
Upgrade
Change in Unearned Revenue
0.07-1.548.34--
Upgrade
Change in Other Net Operating Assets
-5.98-5.07-0.72-5.2-2.35
Upgrade
Operating Cash Flow
-225.97-166.31-115.21-88.59-62.03
Upgrade
Capital Expenditures
-3.84-4.69-1.66-0.44-0.19
Upgrade
Investment in Securities
-570.97-195.73-172.32-56.050.4
Upgrade
Investing Cash Flow
-574.82-200.41-173.98-56.480.22
Upgrade
Issuance of Common Stock
1,060411.68129.72265.64122.07
Upgrade
Other Financing Activities
-49.44-22.74-7.76-12.96-7.5
Upgrade
Financing Cash Flow
1,010388.94121.96252.68114.57
Upgrade
Net Cash Flow
209.6522.22-167.22107.6152.76
Upgrade
Free Cash Flow
-229.81-171-116.86-89.02-62.21
Upgrade
Free Cash Flow Margin
-22118.77%-4261.03%-2466.98%-8258.26%-87623.94%
Upgrade
Free Cash Flow Per Share
-2.85-2.94-2.25-2.32-2.04
Upgrade
Levered Free Cash Flow
-136.41-93.53-62.51-48.47-35.28
Upgrade
Unlevered Free Cash Flow
-136.41-93.53-62.51-48.47-35.28
Upgrade
Change in Net Working Capital
-7.04-8.26-11.87-1-0.37
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q